• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部免疫疗法改变斑秃患者球周浸润的组成。

Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata.

作者信息

Happle R, Klein H M, Macher E

出版信息

Arch Dermatol Res. 1986;278(3):214-8. doi: 10.1007/BF00412926.

DOI:10.1007/BF00412926
PMID:2873796
Abstract

It has previously been shown that, in patients with untreated progressive alopecia areata (AA), the peribulbar T4/T8 ratio is about 4:1. In the present study, the immunohistochemical findings obtained in untreated AA patients were compared to those obtained in patients who had received topical immunotherapy with diphencyprone. The untreated group consisted of 5 patients with progressive AA and 5 patients with inactive AA. The treated group consisted of 5 patients with a good response to diphencyprone and 5 patients with little or no hair regrowth after treatment. In untreated patients with progressive AA, the mean peribulbar T4/T8 ratio was 4:1, whereas in untreated patients with stable AA, the ratio was 2:1. In the treated patients with a good response to diphencyprone, the mean T4/T8 ratio was 1:1, while in the patients with poor or no response to treatment, the ratio was 0.7. In conclusion, topical immunotherapy considerably alters the peribulbar T4/T8 ratio in AA. The results are consistent with, but do not prove, the concept of topical immunomodulation.

摘要

此前已有研究表明,在未经治疗的进展期斑秃(AA)患者中,球周T4/T8比值约为4:1。在本研究中,将未经治疗的AA患者的免疫组化结果与接受二苯环丙烯酮局部免疫治疗的患者的结果进行了比较。未治疗组包括5例进展期AA患者和5例静止期AA患者。治疗组包括5例对二苯环丙烯酮反应良好的患者和5例治疗后几乎没有或没有毛发再生的患者。在未经治疗的进展期AA患者中,球周T4/T8平均比值为4:1,而在未经治疗的静止期AA患者中,该比值为2:1。在对二苯环丙烯酮反应良好的治疗患者中,T4/T8平均比值为1:1,而在对治疗反应不佳或无反应的患者中,该比值为0.7。总之,局部免疫治疗可显著改变AA患者的球周T4/T8比值。这些结果与局部免疫调节的概念一致,但并未证实这一概念。

相似文献

1
Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata.局部免疫疗法改变斑秃患者球周浸润的组成。
Arch Dermatol Res. 1986;278(3):214-8. doi: 10.1007/BF00412926.
2
Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.二苯环丙烯酮治疗前后斑秃中血管内皮生长因子、凋亡抑制因子(生存素和p16)及CCL27的表达:一项免疫组织化学研究
Br J Dermatol. 2004 May;150(5):940-8. doi: 10.1111/j.1365-2133.2004.05881.x.
3
Alopecia areata: topical immunotherapy treatment with diphencyprone.斑秃:二苯环丙烯酮局部免疫疗法治疗
J Eur Acad Dermatol Venereol. 2008 Mar;22(3):320-3. doi: 10.1111/j.1468-3083.2007.02411.x. Epub 2007 Nov 12.
4
Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata.斑秃患者球周和球内浸润中T细胞亚群的免疫组织化学分析
Acta Derm Venereol. 1984;64(1):26-30.
5
Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.二苯环丙烯酮免疫疗法可改变斑秃患者的抗毛囊抗体状态。
Eur J Dermatol. 2002 Jul-Aug;12(4):327-34.
6
Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.单独使用二苯环丙烯酮或联合蒽林治疗慢性广泛型斑秃的疗效和安全性:一项回顾性病例系列研究。
J Am Acad Dermatol. 2015 Apr;72(4):640-50. doi: 10.1016/j.jaad.2015.01.008. Epub 2015 Feb 1.
7
Five-year experience in the treatment of alopecia areata with DPC.采用 DPC 治疗斑秃的 5 年经验。
J Eur Acad Dermatol Venereol. 2010 Mar;24(3):264-9. doi: 10.1111/j.1468-3083.2009.03401.x. Epub 2009 Sep 8.
8
Restoration of hair growth with topical diphencyprone in mouse and rat models of alopecia areata.
J Am Acad Dermatol. 2003 Dec;49(6):1013-9. doi: 10.1016/s0190-9622(03)02141-8.
9
Alopecia areata-like hair loss in C3H/HeJ mice and DEBR rats can be reversed using topical diphencyprone.
J Investig Dermatol Symp Proc. 1999 Dec;4(3):239. doi: 10.1038/sj.jidsp.5640219.
10
Topical immunotherapy in alopecia areata: anamnestic and clinical criteria of prognostic significance.斑秃的局部免疫疗法:具有预后意义的既往史和临床标准
Dermatology. 1996;192(2):129-33. doi: 10.1159/000246337.

引用本文的文献

1
Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options.斑秃:诊断、免疫学发病机制及治疗选择的综述。
Clin Exp Med. 2021 May;21(2):215-230. doi: 10.1007/s10238-020-00673-w. Epub 2021 Jan 1.
2
Comparative Study of Efficacy and Safety of Topical Squaric Acid Dibutylester and Diphenylcyclopropenone for the Treatment of Alopecia Areata.局部用二丁基酒石酸和二苯基环丙烯酮治疗斑秃的疗效与安全性对比研究
N Am J Med Sci. 2016 Jun;8(6):237-42. doi: 10.4103/1947-2714.185029.
3
Alopecia areata: a new treatment plan.

本文引用的文献

1
In situ demonstration of T cells in alopecia areata.斑秃中T细胞的原位显示
Arch Dermatol Res. 1982;273(1-2):155-8. doi: 10.1007/BF00509041.
2
Immunohistological analysis of delayed-type hypersensitivity in man.人类迟发型超敏反应的免疫组织学分析。
Cell Immunol. 1982 Dec;74(2):358-69. doi: 10.1016/0008-8749(82)90036-3.
3
Immunological profiles in alopecia areata.斑秃的免疫学特征。
斑秃:一种新的治疗方案。
Clin Cosmet Investig Dermatol. 2011;4:107-15. doi: 10.2147/CCID.S22767. Epub 2011 Jul 22.
4
Alopecia totalis in a patient with Crohn's disease and its treatment with azathioprine.一名克罗恩病患者的全秃及其硫唑嘌呤治疗
Postgrad Med J. 1989 Mar;65(761):188-9. doi: 10.1136/pgmj.65.761.188.
5
Evolutionary changes of immunohistological characteristics of secondary lesions in pityriasis rosea.
Arch Dermatol Res. 1988;280(7):405-10. doi: 10.1007/BF00429978.
6
Topical immunotherapy with contact allergens in alopecia areata: evidence for non-specific systemic suppression of cellular immune reactions.斑秃中使用接触变应原的局部免疫疗法:细胞免疫反应非特异性全身抑制的证据
Arch Dermatol Res. 1991;283(2):133-4. doi: 10.1007/BF00371623.
Br J Dermatol. 1984 Feb;110(2):163-70. doi: 10.1111/j.1365-2133.1984.tb07462.x.
4
Intrabulbar and peribulbar accumulation of dendritic OKT 6-positive cells in alopecia areata.斑秃中球内和球周树突状OKT 6阳性细胞的积聚。
Arch Dermatol Res. 1984;276(5):333-4. doi: 10.1007/BF00404628.
5
Antigenic competition as a therapeutic concept for alopecia areata.抗原竞争作为斑秃的一种治疗理念。
Arch Dermatol Res. 1980;267(1):109-14. doi: 10.1007/BF00416931.
6
Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage.抗Leu-3/T4抗体与单核细胞/巨噬细胞系及朗格汉斯细胞系的细胞发生反应。
J Immunol. 1983 Jul;131(1):212-6.
7
T cell subpopulations in alopecia areata.
J Am Acad Dermatol. 1984 Aug;11(2 Pt 1):216-23. doi: 10.1016/s0190-9622(84)70152-6.
8
Suppressor cell number and function in alopecia areata.斑秃中抑制性细胞的数量与功能
Arch Dermatol. 1984 Feb;120(2):188-94.
9
Suppressor cell decrease in alopecia areata.斑秃中抑制细胞减少。
Arch Dermatol Res. 1982;274(1-2):1-8. doi: 10.1007/BF00510352.
10
Alopecia areata: pathogenesis and treatment.斑秃:发病机制与治疗
J Am Acad Dermatol. 1984 Nov;11(5 Pt 1):763-75. doi: 10.1016/s0190-9622(84)80450-8.